Enumeral Biomedical
Latest round
- Series B
Last raised
- May 2014
Total raised
- $2M
Investors
- 2
About Enumeral Biomedical
Founded in 2009 and headquartered in New York, US, Enumeral Biomedical specializes in innovative biotechnological solutions. The company has undergone significant strategic pivots to enhance its research capabilities.Enumeral Biomedical employs a unique platform to facilitate the discovery of immune system interactions and their implications in cancer therapy. It serves a broad clientele, including pharmaceutical companies and research institutions, aiming to improve therapeutic outcomes through enhanced understanding of immune responses.In the most recent year, 2016, Enumeral Biomedical reported a revenue of USD 2,452,868.5 mn is earmarked for advancing its research and development initiatives, with plans to launch new products aimed at enhancing cancer therapies by 2025. The company is also strategizing to expand its presence in European markets, specifically targeting collaborations with leading pharmaceutical firms, which is anticipated to further establish its footprint in the biotechnology landscape.
Who invested in Enumeral Biomedical
2 investors across 1 round
See all investors in Enumeral Biomedical
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series B
May 7, 2014
Amount
$2M
Investors
Questions about Enumeral Biomedical
Who invested in Enumeral Biomedical?
Enumeral Biomedical has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Enumeral Biomedical raised?
Enumeral Biomedical has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Enumeral Biomedical last raise money?
Enumeral Biomedical's most recent round on record is a Series B, in May 2014.
What does Enumeral Biomedical do?
Founded in 2009 and headquartered in New York, US, Enumeral Biomedical specializes in innovative biotechnological solutions.
Where is Enumeral Biomedical headquartered?
Enumeral Biomedical is headquartered in New York, US.
Which VCs invest in companies like Enumeral Biomedical?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Enumeral Biomedical's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Enumeral Biomedical? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.